Regulation of collagenolytic activity using platelet preparations <i>in vitro</i>

Purpose: to study different platelet preparations' impact on collagenase activity in vitro. Materials and methods. Human amnion transplants and collagen covers, based on human type 1 collagen, were used as collagen matrices. The drug Fermencol was used as a source of collagen-lytic peptidases....

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Chentsova, N. V. Borovkova, K. V. Sirotkina, M. S. Makarov, M. V. Storozheva, I. N. Ponomarev
Format: Article
Language:Russian
Published: Real Time Ltd 2025-03-01
Series:Российский офтальмологический журнал
Subjects:
Online Access:https://roj.igb.ru/jour/article/view/1714
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850047504498819072
author E. V. Chentsova
N. V. Borovkova
K. V. Sirotkina
M. S. Makarov
M. V. Storozheva
I. N. Ponomarev
author_facet E. V. Chentsova
N. V. Borovkova
K. V. Sirotkina
M. S. Makarov
M. V. Storozheva
I. N. Ponomarev
author_sort E. V. Chentsova
collection DOAJ
description Purpose: to study different platelet preparations' impact on collagenase activity in vitro. Materials and methods. Human amnion transplants and collagen covers, based on human type 1 collagen, were used as collagen matrices. The drug Fermencol was used as a source of collagen-lytic peptidases. We used platelet-rich plasma (PRP); concentrated suspension of platelets washed from plasma (WP); platelet-poor plasma (PPP); lysates of PRP, PPP and WP. To assess the collagen-lytic activity we studied the level of collagen autofluorescence in tissue grafts, collagen concentration in solution, proliferation intensity of mesenchymal multipotent stromal cells (MMSC) on the surface of the grafts. Results. Preparations based on PRP and WP stimulated significant inhibition of collagen-lytic activity, which was absent in PPP. The inhibition of collagen-lytic effect in PRP and WP depended on the initial content of platelets with granules. Platelet preparations significantly enhanced the adhesion and growth of MMSC on the surface of the amnion and collagen cover. Conclusion. The use of platelet lysates combined high inhibition of collagen-lytic peptidases and growth-stimulating effect, which persists even with dilution of PRP lysate in ratio 1:200. For effective inhibition of collagen-lytic peptidases is recommended to use PRP with initial concentration of platelets with granules at least 350 thousand/ml.
format Article
id doaj-art-ccdcdc4c50cc4d28afc900f5e61d7dfa
institution DOAJ
issn 2072-0076
2587-5760
language Russian
publishDate 2025-03-01
publisher Real Time Ltd
record_format Article
series Российский офтальмологический журнал
spelling doaj-art-ccdcdc4c50cc4d28afc900f5e61d7dfa2025-08-20T02:54:11ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602025-03-01181929910.21516/2072-0076-2025-18-1-92-99762Regulation of collagenolytic activity using platelet preparations <i>in vitro</i>E. V. Chentsova0N. V. Borovkova1K. V. Sirotkina2M. S. Makarov3M. V. Storozheva4I. N. Ponomarev5Helmholtz National Medical Research Center of Eye DiseasesN.V. Sklifosovsky Research Institute for Emergency Medicine; Pirogov Russian National Research Medical UniversityHelmholtz National Medical Research Center of Eye DiseasesN.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicineN.V. Sklifosovsky Research Institute for Emergency MedicinePurpose: to study different platelet preparations' impact on collagenase activity in vitro. Materials and methods. Human amnion transplants and collagen covers, based on human type 1 collagen, were used as collagen matrices. The drug Fermencol was used as a source of collagen-lytic peptidases. We used platelet-rich plasma (PRP); concentrated suspension of platelets washed from plasma (WP); platelet-poor plasma (PPP); lysates of PRP, PPP and WP. To assess the collagen-lytic activity we studied the level of collagen autofluorescence in tissue grafts, collagen concentration in solution, proliferation intensity of mesenchymal multipotent stromal cells (MMSC) on the surface of the grafts. Results. Preparations based on PRP and WP stimulated significant inhibition of collagen-lytic activity, which was absent in PPP. The inhibition of collagen-lytic effect in PRP and WP depended on the initial content of platelets with granules. Platelet preparations significantly enhanced the adhesion and growth of MMSC on the surface of the amnion and collagen cover. Conclusion. The use of platelet lysates combined high inhibition of collagen-lytic peptidases and growth-stimulating effect, which persists even with dilution of PRP lysate in ratio 1:200. For effective inhibition of collagen-lytic peptidases is recommended to use PRP with initial concentration of platelets with granules at least 350 thousand/ml.https://roj.igb.ru/jour/article/view/1714amnioncollagenplateletsanti-collagenase activityautofluorescenceproliferation
spellingShingle E. V. Chentsova
N. V. Borovkova
K. V. Sirotkina
M. S. Makarov
M. V. Storozheva
I. N. Ponomarev
Regulation of collagenolytic activity using platelet preparations <i>in vitro</i>
Российский офтальмологический журнал
amnion
collagen
platelets
anti-collagenase activity
autofluorescence
proliferation
title Regulation of collagenolytic activity using platelet preparations <i>in vitro</i>
title_full Regulation of collagenolytic activity using platelet preparations <i>in vitro</i>
title_fullStr Regulation of collagenolytic activity using platelet preparations <i>in vitro</i>
title_full_unstemmed Regulation of collagenolytic activity using platelet preparations <i>in vitro</i>
title_short Regulation of collagenolytic activity using platelet preparations <i>in vitro</i>
title_sort regulation of collagenolytic activity using platelet preparations i in vitro i
topic amnion
collagen
platelets
anti-collagenase activity
autofluorescence
proliferation
url https://roj.igb.ru/jour/article/view/1714
work_keys_str_mv AT evchentsova regulationofcollagenolyticactivityusingplateletpreparationsiinvitroi
AT nvborovkova regulationofcollagenolyticactivityusingplateletpreparationsiinvitroi
AT kvsirotkina regulationofcollagenolyticactivityusingplateletpreparationsiinvitroi
AT msmakarov regulationofcollagenolyticactivityusingplateletpreparationsiinvitroi
AT mvstorozheva regulationofcollagenolyticactivityusingplateletpreparationsiinvitroi
AT inponomarev regulationofcollagenolyticactivityusingplateletpreparationsiinvitroi